Stock Price Quote for REGN
What does Regeneron Pharmaceuticals do?
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. To learn more, visit their official website at regeneron.com.
Where is Regeneron Pharmaceuticals located?
Regeneron Pharmaceuticals is headquartered in Tarrytown, New York. Their full address is 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707, United States.
What exchange is Regeneron Pharmaceuticals traded on?
Shares for Regeneron Pharmaceuticals are traded on the Nasdaq exchange under ticker symbol "REGN".
What industry is Regeneron Pharmaceuticals in?
Regeneron Pharmaceuticals operates in the Health Care/Life Sciences sector while being primarily involved in the Biotechnology industry.
Similar Size Companies also in the Biotechnology Industry
Large Companies also in New York
- JP Morgan Chase & Co.
- Mastercard Incorporated
- Morgan Stanley
- Philip Morris International Inc
- American Express Company
- Bristol-Myers Squibb Company
- The Goldman Sachs Group
- International Business Machines Corporation
- The Estee Lauder Companies
- S&P Global
- Marsh & McLennan Companies
- Moody's Corporation
- Colgate-Palmolive Company
- MSCI Inc
Investomatica Comment Policy
Discussions are welcome. Please stay on topic and remember to be kind to each other. If you would like to report a bug or issue with one of our pages or calculators, please direct message us on twitter instead.